UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000022334
Receipt No. R000025742
Scientific Title Factual investigation on glaucoma
Date of disclosure of the study information 2016/05/18
Last modified on 2022/05/24 (Ver. 8)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Factual investigation on glaucoma
Acronym Factual investigation on glaucoma
Scientific Title Factual investigation on glaucoma
Scientific Title:Acronym Factual investigation on glaucoma
Region
Japan

Condition
Condition Glaucoma
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 Factual investigation based on analysis and data collected from patients with primary open angle glaucoma
Basic objectives2 Others
Basic objectives -Others To examine the factors associated with glaucoma
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes The factor which participates in glaucoma
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit

Not applicable
Gender Male and Female
Key inclusion criteria Patients who visit Yoshikawa Eye Clinic twice or more with at least one eye meets all the following criteria are included in this study.
1. Diagnosed as open angle glaucoma
2. First visit to this clinic was at age of 20 or older
Key exclusion criteria Not applicable
Target sample size 400

Research contact person
Name of lead principal investigator
1st name 1. Keiji Yoshikawa
Middle name
Last name 2. Masayo Hashimoto
Organization 1. Yoshikawa Eye Clinic
2. Santen Pharmaceutical Co., Ltd.
Division name 1. Yoshikawa Eye Clinic 2. Japan Medical Affairs Medical Affairs Global R&D
Zip code 1.194-0021 2.530-0011
Address 1. 1-3-1 Nakamachi, Machida, Tokyo 2. 4-20 Ohukacho, Kitaku, Osaka
TEL 042-739-0781
Email yoshi0781.auge@gmail.com

Public contact
Name of contact person
1st name Keiji
Middle name
Last name Yoshikawa
Organization Yoshikawa Eye Clinic
Division name Yoshikawa Eye Clinic
Zip code 194-0021
Address 1-3-1 Nakamachi, Machida, Tokyo
TEL 042-739-0781
Homepage URL
Email yoshi0781.auge@gmail.com

Sponsor
Institute Yoshikawa Eye Clinic
Institute
Department

Funding Source
Organization Santen Pharmaceutical Co., Ltd.
Organization
Division
Category of Funding Organization Profit organization
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kyoyukai RiverSide Clinic
Address 2-1 Minami 7 Jo Nishi, Chuoku, Sapporo, Hokkaido
Tel 011-521-2321
Email rinrishinsa@riversideclinic.or.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions 吉川眼科クリニック(東京都)/ Yoshikawa Eye Clinic(Tokyo)

Other administrative information
Date of disclosure of the study information
2016 Year 05 Month 18 Day

Related information
URL releasing protocol Not applicable
Publication of results Published

Result
URL related to results and publications https://doi.org/10.2147/OPTH.S146455 , https://doi.org/10.2147/OPTH.S172273
Number of participants that the trial has enrolled 311
Results Refer to published paper
Results date posted
2022 Year 05 Month 24 Day
Results Delayed
Results Delay Reason
Date of the first journal publication of results
2018 Year 01 Month 31 Day
Baseline Characteristics Refer to published paper
Participant flow Refer to published paper
Adverse events Refer to published paper
Outcome measures Refer to published paper
Plan to share IPD The datasets are not publicly available, but are available from the corresponding author on reasonable request.
IPD sharing Plan description The datasets are not publicly available, but are available from the corresponding author on reasonable request.

Progress
Recruitment status Completed
Date of protocol fixation
2016 Year 04 Month 11 Day
Date of IRB
2016 Year 04 Month 26 Day
Anticipated trial start date
2016 Year 05 Month 19 Day
Last follow-up date
2019 Year 06 Month 24 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information This is a retrospective study using data from an institution for the factual investigation of glaucoma.
Data from patients who visited Yoshikawa Eye Clinic from April 2006 to March 2016 and met all the inclusion criteria are collected and analyzed for the investigation.

Management information
Registered date
2016 Year 05 Month 17 Day
Last modified on
2022 Year 05 Month 24 Day


Link to view the page
URL(English) https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000025742